Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Paclitaxel-induced Peripheral Neuropathy in Ovarian Cancer
NCT05539053Completed
- Sponsor
- Ministry of Public Health
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in peripheral neuropathy (3 arms), sponsored by Ministry of Public Health. Primary endpoint: Paclitaxel-induced peripheral neuropathy. Started Nov 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT05539053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05539053.